Cargando…
Functions of the Alzheimer’s Disease Protease BACE1 at the Synapse in the Central Nervous System
Inhibition of the protease β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) is a promising treatment strategy for Alzheimer’s disease, and a number of BACE inhibitors are currently progressing through clinical trials. The strategy aims to decrease production of amyloid-β (Aβ) peptide from...
Autores principales: | Munro, Kathryn M., Nash, Amelia, Pigoni, Martina, Lichtenthaler, Stefan F., Gunnersen, Jenny M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059407/ https://www.ncbi.nlm.nih.gov/pubmed/27456313 http://dx.doi.org/10.1007/s12031-016-0800-1 |
Ejemplares similares
-
Seizure-6 proteins highlight BACE1 functions in neurobiology
por: Pigoni, Martina, et al.
Publicado: (2016) -
Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
por: Pigoni, Martina, et al.
Publicado: (2016) -
The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond
por: Dislich, Bastian, et al.
Publicado: (2012) -
Tau deletion reduces plaque‐associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease
por: Peters, Finn, et al.
Publicado: (2019) -
BACE inhibitor treatment of mice induces hyperactivity in a Seizure-related gene 6 family dependent manner without altering learning and memory
por: Nash, A., et al.
Publicado: (2021)